The drug is available as a weight-loss medication under the brand name Wegovy and will now also be sold directly to diabetes ...

Viking Therapeutics, Inc.'s obesity drug VK2735 results reveal no clear edge over leading competitors. Click for why this ...

Beneficiaries using Tricare Prime, Tricare Standard and premium-based plans will continue to have access but must meet specific criteria.

Eli Lilly and Novo Nordisk are expected to price their new obesity pills in line with existing injections, as analysts cite ...

Novo Nordisk is slashing the price of its blockbuster diabetes drug Ozempic for U.S. patients who self-pay or are uninsured.

Although the FDA has since removed these drugs from its shortage list, stakeholders say compounded drugs continue to be sold.

Wegovy is now positioned as the first and only GLP-1 treatment.

The company is the latest facing historic losses as pharmaceutical firms compete to develop a weight-loss pill.

Novo Nordisk announced Monday that U.S. patients can now get a month's supply of Ozempic, the blockbuster diabetes drug, for ...

While the 10-fold increase in dose over injectable Wegovy has raised questions about the launch, Novo Nordisk has assured ...

Dr. Melanie Bone weighed in after one Ozempic user took to Reddit to share an unexpected outcome of taking the medication ...